Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system.

Megan E V Caram,Kyle Kumbier,Jennifer Burns,Jordan B Sparks,Phoebe A Tsao,Kristian D Stensland,Samuel L Washington,Brent K Hollenbeck,Vahakn Shahinian,Ted A Skolarus

Cancer medicine（2023）

引用 0|浏览14

暂无评分

摘要

Many facilities persisted in their use of ketoconazole as first-line CRPC therapy, even when other facilities had adopted the new standard of care abiraterone and enzalutamide. Further work is needed to identify the effect of this late adoption on outcomes important to patients.

查看译文

关键词

adoption of technology,facility,prostate cancer,rural care,variation in care

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要